Tarodyl en es it fr

Tarodyl Brand names, Tarodyl Analogs

Tarodyl Brand Names Mixture

  • No information avaliable

Tarodyl Chemical_Formula


Tarodyl RX_link


Tarodyl fda sheet

Tarodyl FDA

Tarodyl msds (material safety sheet)

Tarodyl MSDS

Tarodyl Synthesis Reference

No information avaliable

Tarodyl Molecular Weight

318.431 g/mol

Tarodyl Melting Point

192.5 oC

Tarodyl H2O Solubility

No information avaliable

Tarodyl State


Tarodyl LogP


Tarodyl Dosage Forms

Liquid; Tablet

Tarodyl Indication

For use as a preoperative antimuscarinic to reduce salivary, tracheobronchial, and pharyngeal secretions, to reduce the volume and free acidity of gastric secretions and to block cardiac vagal inhibitory reflexes during induction of anesthesia and intubation.

Tarodyl Pharmacology

Glycopyrrolate decreases acid secretion in the stomach. Hence it can be used for treating ulcers in the stomach and small intestine, in combination with other medications. In anesthesia, glycopyrrolate injection serves as a preoperative antimuscarinic operation that reduces salivary, tracheobronchial, and pharyngeal secretions, as well as decreases the acidity of gastric secretions blocks cardiac vagal inhibitory reflexes during intubation

Tarodyl Absorption

Rapidly absorbed (1-2 minutes) after intravenous injection

Tarodyl side effects and Toxicity

Side effects include dry mouth, difficult urinating, heachaches, diarrhea and constipation. The medication also induces drowsiness or blurred vision. LD50=709 mg/kg (rat, oral).

Tarodyl Patient Information

No information avaliable

Tarodyl Organisms Affected

Humans and other mammals